MMRV vaccine
Combination vaccine against measles, mumps, rubella, and varicella viruses / From Wikipedia, the free encyclopedia
The MMRV vaccine is a combination vaccine which combines the attenuated virus measles, mumps, rubella (German measles), and varicella (chickenpox). The MMRV vaccine has similar immunogenicity and overall safety profiles to the MMR vaccine administered with or without the varicella vaccine. The MMRV vaccine is typically given to children between one and two years of age.[8]
Quick Facts Combination of, Measles vaccine ...
Combination of | |
---|---|
Measles vaccine | Vaccine |
Mumps vaccine | Vaccine |
Rubella vaccine | Vaccine |
Varicella vaccine | Vaccine |
Clinical data | |
Trade names | Proquad, Priorix Tetra |
Other names | Measles, Mumps, Rubella, and Varicella Virus Vaccine Live |
AHFS/Drugs.com | Monograph |
License data | |
Pregnancy category |
|
Routes of administration | Subcutaneous, intramuscular |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
ChemSpider |
|
NY (what is this?) (verify) |
Close
Several companies supply MMRV vaccines. Proquad is marketed by Merck and was approved in 2005, for use in the United States by the Food and Drug Administration (FDA) for children ages twelve months through twelve years. An MMRV vaccine called Priorix Tetra[9][10] by GlaxoSmithKline has been approved in Germany and Australia.[11][12][13]